135 related articles for article (PubMed ID: 37252417)
1. New-onset Thyroid Eye Disease after COVID-19 Vaccination in a Radioactive Iodine-Treated Graves' Disease Patient: A Case Report and Literature Review.
Im Teoh JH; Mustafa N; Wahab N
J ASEAN Fed Endocr Soc; 2023; 38(1):125-130. PubMed ID: 37252417
[TBL] [Abstract][Full Text] [Related]
2. Thyroid Inflammation and Immunity During the COVID-19 Pandemic: A Comprehensive Review and Case Study.
Lampropoulou E; Benz C; Kahaly GJ; Führer D
Horm Metab Res; 2024 Feb; 56(2):111-117. PubMed ID: 38049146
[TBL] [Abstract][Full Text] [Related]
3. Thyroid Eye Disease Following COVID-19 Vaccine in a Patient With a History Graves' Disease: A Case Report.
Rubinstein TJ
Ophthalmic Plast Reconstr Surg; 2021 Nov-Dec 01; 37(6):e221-e223. PubMed ID: 34570048
[TBL] [Abstract][Full Text] [Related]
4. Thyroid storm after coronavirus disease 2019 mRNA vaccination in a patient with a history of Graves' disease after coronavirus disease 2019 infection.
Saito M; Iijima T; Kurai H; Aso Y
BMJ Case Rep; 2024 Jun; 17(6):. PubMed ID: 38834307
[TBL] [Abstract][Full Text] [Related]
5. Increased Risk of Thyroid Eye Disease Following Covid-19 Vaccination.
Muller I; Consonni D; Crivicich E; Di Marco F; Currò N; Salvi M
J Clin Endocrinol Metab; 2024 Jan; 109(2):516-526. PubMed ID: 37622279
[TBL] [Abstract][Full Text] [Related]
6. Graves' Disease after Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine in a Type 1 Diabetes Patient.
Sakai M; Takao K; Kato T; Ito K; Kubota S; Hirose T; Liu Y; Mizuno M; Hirota T; Suwa T; Horikawa Y; Yabe D
Intern Med; 2022; 61(10):1561-1565. PubMed ID: 35569928
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 vaccination and thyroiditis.
Şendur SN; Oğuz SH; Ünlütürk U
Best Pract Res Clin Endocrinol Metab; 2023 Jul; 37(4):101759. PubMed ID: 36933997
[TBL] [Abstract][Full Text] [Related]
8. Concurrent pretibial myxedema and thyroid eye disease following mRNA COVID-19 vaccine in a patient with history of Graves' disease.
Caron P; Imbert P; Dekeister C; Grunenwald S
Ann Endocrinol (Paris); 2024 Apr; 85(2):100-103. PubMed ID: 37866430
[TBL] [Abstract][Full Text] [Related]
9. Re: "Thyroid Eye Disease Following COVID-19 Vaccine in a Patient With a History Graves' Disease: A Case Report".
Sriwijitalai W; Wiwanitkit V
Ophthalmic Plast Reconstr Surg; 2022 Jan-Feb 01; 38(1):95. PubMed ID: 34982065
[No Abstract] [Full Text] [Related]
10. Reply re: "Thyroid Eye Disease Following COVID-19 Vaccine in a Patient With a History Graves' Disease: A Case Report".
Rubinstein T
Ophthalmic Plast Reconstr Surg; 2022 Jan-Feb 01; 38(1):95-96. PubMed ID: 34982066
[No Abstract] [Full Text] [Related]
11. Thyroid Eye Disease as Initial Manifestation of Graves' Disease Following Viral Vector SARS-CoV-2 Vaccine: Report of a Case and Review of the Literature.
Armeni AK; Markantes GΚ; Stathopoulou A; Saltiki K; Zampakis P; Assimakopoulos SF; Michalaki MA
Vaccines (Basel); 2023 Oct; 11(10):. PubMed ID: 37896977
[TBL] [Abstract][Full Text] [Related]
12. Thyroid disturbances after COVID-19 and the effect of vaccination in children: a prospective tri-center registry analysis.
Herczeg V; Garai R; Takács J; Kovács F; Luczay A; Hrapka E; Krivácsy P; Hosszú É; Beniczky NJ; Németh Á; Szilágyi ES; Pécsi A; Szabó Z; Szabó AJ; Tóth-Heyn P
Eur J Pediatr; 2023 Oct; 182(10):4443-4455. PubMed ID: 37488409
[TBL] [Abstract][Full Text] [Related]
13. A Review of Thyroid Dysfunction Due to COVID-19.
Arefzadeh A
Mini Rev Med Chem; 2024; 24(3):265-271. PubMed ID: 37069724
[TBL] [Abstract][Full Text] [Related]
14. Severe coronary artery spasm after administration of a 5-hydroxytryptamine type 1 receptor agonist in a patient with new-onset Graves' disease and myocarditis after SARS-CoV2 vaccination.
Vandebosch C; Dupont M; Verhaert D; Mullens W
Acta Cardiol; 2023 Oct; 78(8):889-893. PubMed ID: 36597848
[TBL] [Abstract][Full Text] [Related]
15. Two Cases of Severe Autoimmune Thyrotoxicosis Following SARS-CoV-2 Infection.
Edwards K; Hussain I
J Investig Med High Impact Case Rep; 2021; 9():23247096211056497. PubMed ID: 34844465
[TBL] [Abstract][Full Text] [Related]
16. Thyroid Eye Disease: Epidemiology, Natural History, and Risk Factors.
Bartalena L; Gallo D; Tanda ML; Kahaly GJ
Ophthalmic Plast Reconstr Surg; 2023 Dec; 39(6S):S2-S8. PubMed ID: 38054980
[TBL] [Abstract][Full Text] [Related]
17. New-Onset Acute Interstitial Nephritis Post-SARS-CoV-2 Infection and COVID-19 Vaccination: A Panoramic Review.
Wang Y; Yang L; Xu G
J Epidemiol Glob Health; 2023 Dec; 13(4):615-636. PubMed ID: 37870719
[TBL] [Abstract][Full Text] [Related]
18. A case of IgG4-related ophthalmic disease after SARS-CoV-2 vaccination: case report and literature review.
Zhang P; Wu Q; Xu X; Chen M
Front Immunol; 2024; 15():1303589. PubMed ID: 38455056
[TBL] [Abstract][Full Text] [Related]
19. Ocular Adverse Events After COVID-19 Vaccination.
Ng XL; Betzler BK; Testi I; Ho SL; Tien M; Ngo WK; Zierhut M; Chee SP; Gupta V; Pavesio CE; de Smet MD; Agrawal R
Ocul Immunol Inflamm; 2021 Aug; 29(6):1216-1224. PubMed ID: 34559576
[TBL] [Abstract][Full Text] [Related]
20. New-onset Immune-mediated Necrotizing Myopathy and Trigeminal Neuropathy after SARS-CoV-2 mRNA Vaccination in a Patient with Rheumatoid Arthritis and Sjögren's Syndrome.
Tsuzuki Wada T; Yokota K; Inayoshi F; Sakai S; Okumura N; Matsuda M; Osawa I; Araki Y; Funakubo Asanuma Y; Akiyama Y; Mimura T
Intern Med; 2023 Dec; 62(24):3699-3706. PubMed ID: 37839879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
